Changes in psychiatric symptoms among persons with methamphetamine dependence predicts changes in severity of drug problems but not frequency of use

References

• Clark HW, Power AK, LeFauve CE, Lopez EI. Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders. J Subst Abuse Treat. 2008;34:3–13.
   PubMed Web of Science ®Google Scholar
• Havassy BE, Alvidrez J, Owen KK. Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. Am J Psychiatry. 2004;161:139–145.
   PubMed Web of Science ®Google Scholar
• Kay-Lambkin FJ, Baker AL, Lee NM, Jenner L, Lewin TJ. The influence of depression on treatment for methamphetamine use. Med J Aust. 2011;195:S38–S43.
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse MP, Ang A, Rawson RA. Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug Alcohol Rev. 2010; 29:12–20.
   PubMed Web of Science ®Google Scholar
• McKetin R, Lubman DI, Lee NM, Ross JE, Slade TN. Major depression among methamphetamine users entering drug treatment programs. Med J Aust. 2011;195:S51–S55.
   PubMed Web of Science ®Google Scholar
• Drake RE, Mueser KT, Brunette MF, McHugo GJ. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehabil J. 2004;27:360–374.
   PubMed Web of Science ®Google Scholar
• Medhus S, Holm B, Mørland J, Bramness JG. Association between methamphetamine versus amphetamine and acute psychiatric symptoms. J Dual Diag. 2013;9:292–300.
   Web of Science ®Google Scholar
• Russell K, Dryden DM, Liang Y, et al. Risk factors for methamphetamine use in youth: a systematic review. BMC Pediatrics. 2008;8:48.
   PubMed Web of Science ®Google Scholar
• Polcin DL, Buscemi R, Nayak M, Korcha R, Galloway G. Sex differences in psychiatric symptoms among methamphetamine-dependent residents in sober living houses. Addict Disord Their Treat. 2012;11:53–63.
   PubMedGoogle Scholar
• Zimmerman M, Mattia JI. Reliability and validity of a screening questionnaire for 13 DSM-IV Axis I disorders in psychiatric outpatients. J Clin Psychol. 1999;60:677–683.
   Web of Science ®Google Scholar
• Compton WM, 3rd, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry. 2003;160:890–895.
   PubMed Web of Science ®Google Scholar
• Ritsher JB, McKellar JD, Finney JW, Otilingam PG, Moos RH. Psychiatric comorbidity, continuing care and mutual help as predictors of five-year remission from substance use disorders. J Stud Alcohol. 2002;63:709–715.
   PubMed Web of Science ®Google Scholar
• McNulty J, Kouimtsidis C. Outcomes of treatment intervention in drug abuse. Curr Opin Psychiatry. 2001;14:201–205.
   Web of Science ®Google Scholar
• Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R. Anxiety disorders among methamphetamine dependent adults: association with posttreatment functioning. Am J Addict. 2010;19:385–390.
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards S, Marinelli-Casey P, Hillhouse M, Ang A, Mooney LJ, Rawson R. Depression among methamphetamine users: association with outcomes from the methamphetamine treatment project at 3-year follow-up. J Nerv Ment Dis. 2009;197:225–231.
   PubMed Web of Science ®Google Scholar
• Polcin DL, Bond J, Korcha R, Nayak MB, Galloway GP, Evans K. Randomized trial of Intensive Motivational Interviewing for methamphetamine dependence. J Addict Dis. 2014; 33(3): 253-265.
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text rev. Washington, DC: American Psychiatric Publishing; 2000.
   Google Scholar
• Forman RF, Sivikis D, Montoya ID, Blaine J. Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2004;27:1–8.
   PubMed Web of Science ®Google Scholar
• Polcin DL, Brown M, Galloway GP. Intensive Motivational Enhancement Therapy Manual.Berkeley, CA: Alcohol Research Group; 2005.
   Google Scholar
• Galloway GP, Polcin DL, Kielstein A, Brown M, Mendelson J. A nine session manual of motivational enhancement therapy for methamphetamine dependence: adherence and efficacy. J Psychoactive Drugs. 2007;SARC:393–400.
   Google Scholar
• Martino S, Ball SA, Gallon SL, et al. Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency. Salem, OR: Northwest Frontier Addiction Technology Transfer Center, Oregon Health and Science University. Available at: http://www.webcitation.org/6EDD4BNKM. Published 2006. Accessed February 5, 2013.
   Google Scholar
• Nuro KF, Maccarelli L, Martino S, et al. Yale Adherence and Competence Scale (YACSII) Guidelines. West Haven, CT: Yale University Psychotherapy Development Center; 2005.
   Google Scholar
• Galloway GP, Marinelli-Casey P, Stalcup J, et al. Treatment-as-usual in the methamphetamine treatment project. J Psychoactive Drugs. 2000;32:165–175.
   PubMed Web of Science ®Google Scholar
• Sobell LC, Sobell MB, Buchan G, Cleland PA, Fedoroff IC, Leo GI. The reliability of the Timeline Followback method applied to drug, cigarette, and cannabis use. Poster presented at the 30th Annual Meeting of the Association for Advancement of Behavior Therapy, November 21–24, New York, NY.
   Google Scholar
• Carroll KM, Ball SA, Nich C, et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend. 2006;81:301–312.
   PubMed Web of Science ®Google Scholar
• Winhusen T, Kropp F, Babcock D, et al. Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. J Subst Abuse Treat. 2008;35:161–173.
   PubMed Web of Science ®Google Scholar
• Cacciola JS, Alterman AI, McLellan AT, Lin Y-T, Lynch KG. Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index. Drug Alcohol Depend. 2007;87:297–302.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26–33.
   PubMed Web of Science ®Google Scholar
• Ware JH, Dockery DW, Louis TA, Xu X, Ferris BG Jr, Speizer FE. Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults. Am J Epidemiol. 1990; 132:685–700.
   PubMed Web of Science ®Google Scholar
• Diggle PJ, Heagerty P, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. 2nd ed. Oxford, UK: Oxford University Press; 2002.
   Google Scholar
• Stata Corp. Stata Statistical Software: Release 13.0 [computer program]. College Station, TX: Stata Corporation; 2013.
   Google Scholar
• Polcin DL, Beattie M. Relationship and institutional pressure to enter treatment: differences by demographics, problem severity, and motivation. J Stud Alcohol Drugs. 2007;68:428–36.
   PubMed Web of Science ®Google Scholar